Helix Twelve Advantage

The gold standard for treatment is to achieve drugs or drug combinations that effectively treat disease without side-effects. Helix Twelve Pharmaceuticals leverages the extensive drug development experience of its founders to realize that goal.

Clinical trials of HLX-801 in Breast Cancer

  • Proven treatment of advanced ER-positive breast tumors
  • Proven treatment of tumors that do not respond to currently approved treatments

Helix Twelve’s drug development pipeline continues the momentum by applying the same advanced targeting strategies to bring forth innovative therapies in a broad spectrum of syndromes and diseases. With Helix Twelve, one taps into the unprecedented, collective knowledge of a well-honed team that has the demonstrated knowledge and capability of bringing advanced precision therapeutics into today‚Äôs clinical market.